Showing 261-270 of 2478 results for "".
The Anti-Epileptic Effect of REM Sleep
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-anti-epileptic-effect-of-rem-sleep/30416/An emerging theory suggests possible new directions in harnessing the unique ability of REM sleep to prevent seizures.Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/programs/cme/incorporating-fcrn-inhibitors-into-clinical-practice-in-chronic-inflammatory-demyelinating-polyneuropathy/27135/Tune in to learn more about how to incorporate FcRn inhibitors into clinical practice for inflammatory demyelinating polyneuropathy (CIDP).Hypermobility Spectrum Disorders and Migraine: Screening Matters
https://practicalneurology.com/diseases-diagnoses/headache-pain/hypermobility-spectrum-disorders-and-migraine-screening-matters/36118/This article reviews the association between hypermobility spectrum disorders and migraine, highlighting the importance of screening for these disorders in people with migraine to improve diagnosis, management, and outcomes.Chronic Pain: Opioid Tapering
https://practicalneurology.com/diseases-diagnoses/headache-pain/chronic-pain-opioid-tapering/31772/A pragmatic approach may help optimize opioid tapering in adults with chronic pain.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31385/Optimizing Neurology Practice Management: Insights from Parkinson’s LawNeurology practitioners possess extensive knowledge of neurological disorders such as Parkinson’s disease, yet many remain unaware of Parkinson’s Law, a concept introduced by sociologist C. Northcote Parkinson in the 1950s. Parki
Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://practicalneurology.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Functional Weakness and Dysarthria in a 66-Year-Old Man Previously Diagnosed with CIDP
https://practicalneurology.com/diseases-diagnoses/headache-pain/functional-weakness-and-dysarthria-in-a-66-year-old-man-previously-diagnosed-with-cidp/30353/News
https://practicalneurology.com/columns/practice-management/news/30641/Hometown Highlights: CGRP-Related Treatments for Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/hometown-highlights-cgrp-related-treatments-for-headache/30148/Antiplatelet Therapy and Lacunar Stroke: Still a Match
https://practicalneurology.com/diseases-diagnoses/stroke/antiplatelet-therapy-and-lacunar-stroke-still-a-match/30550/A new meta-analysis does not support dual-antiplatelet therapy, but monotherapy may help.